Aggregation of serum proteins with lipopplysaccharide (LPS): Characterization of the precipitable LPS-protein complex

Journal of Endotoxin Research

Volumn 3, Issue 2, 1996, Pages 129-142

  Falk, M C ^a   Fletcher, M A ^a   Williams, T J ^a   Ching, W M ^a   Wu, Y ^a   Morrison, T K ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; PLASMA PROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL AGGREGATION; ENDOTOXEMIA; MICELLE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SEPTIC SHOCK; SURFACE PROPERTY;

EID: 0029894366     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300206     Document Type: Article

References (46)

1. Mathison J.C., Ulevitch R.J. In vivo interaction of bacterial lipopolysaccharide (LPS) with rabbit platelets: modulation by C3 and high density lipoproteins. J Immunol 1981; 126: 1575-1580.
2. Rudbach J.A., Anacker R.L., Haskins W.T., Johnson A.G., Milner K.C., Ribi E. Physical aspects of reversible inactivation of endotoxin. Ann NY Acad Sci 1966; 133: 629-643.
3. Ulevitch R.J. Interactions of bacterial lipopolysaccharides and plasma high density lipoproteins. In: Berry L.J., ed. Handbook of Endotoxin, Vol. 3, Cellular Biology of Endotoxin. Amsterdam: Elsevier, 1985: 372-388.
4. Mathison J.C., Tobias P.S., Wolfson E., Ulevitch R.J. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol 1992; 149: 200-206.
5. Munford R.S., Hall C.L., Dietschy J.M. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun 1981; 34: 835-843.
6. Berer D., Berger H.G. Quantification of the endotoxin-binding capacity of human transferrin. Prog Clin Biol Res 1988; 272: 115-124.
7. Berer D., Kitterer W.R., Berger H.G. Are the serum levels of endotoxin-binding proteins reliable predictors of complications in the course of peritonitis?. Eur J Clin Invest 1990; 20: 66-71.
8. Ohno N., Tanida N., Yadomae T. Characterization of complex formation between lipopolysaccharide and lysozyme. Carbohydr Res 1991; 214: 115-130.
9. Tesh V.L., Vukajlovich S.W., Morrison D.C. Endotoxin interactions with serum proteins: relationship to biological activity. In: Levin J., ten Cate J.W., Buller H.R., van Deventer S.J.H., Sturk A., eds. Bacterial Endotoxins; Pathophysiological Effects, Clinical Significance, and Pharmacological Control. New York: Alan R. Liss, 1988: 47-62.
10. Loos M., Euteneuer B., Clas F. Interaction of bacterial endotoxin (LPS) with fluid phase and macrophage membrane associated C1Q. The FC-recognizing component of the complement system. Adv Exp Med Biol 1990; 256: 301-317.
11. Warren H.S., Novitsky T.J., Martin P., Roslansky P.F., Siber G.R. Endotoxin neutralizing capacity of sera from different patient populations assessed by the Limulus lysate test. Prog Clin Biol Res 1987; 231: 341-348.
12. Warren H.S., Glennon M., de Deckker F.A., Tello D. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other Gram-negative bacteria. J Infect Dis 1991; 163: 1256-1266.
13. Ihara S., Takahashi A., Hatsuse H., Sumitomo K., Doi K., Kawakami M. Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum. J Immunol 1991; 146: 1874-1879.
14. Brade L., Brade H. A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide. Infect Immun 1985; 50: 687-694.
15. Marra M.N., Wilde C.G., Griffith J.E., Snable J.L., Scott R.W. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 1990; 144: 662-666.
16. Schumann R.R., Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
17. Ge Y., Ezzell R.M., Tompkins R.G., Warren H.S. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria. J Infect Dis 1994; 169: 95-104.
18. Tesh V.L., Morrison D.C. The physical-chemical characterization and biologic activity of serum released lipopolysaccharides. J Immunol 1988; 141: 3523-3531.
19. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201.
20. Fink M.P., Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res 1990; 49: 186-196.
21. Silver G.M., Fink M.P. Possible roles for anti- or pro-inflammatory therapies in the management of sepsis. Surg Clin North Am 1994; 74: 711-723.
22. Fink M.P. Adoptive immunotherapy of Gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide. Crit Care Med 1993; 21: S32-S39.
23. Boivin A., Mesrobeanu L. Recherches sur les antigenes somatiques du bacille typhique. Sur la nature chimique des antigenes 'O' et 'Vi'. Comp Rend Soc Biol 1938; 128: 5-8.
24. Webster M.E., Sagin J.F., Landy M., Johnson A.G. Studies on the O antigen of Salmonella, typhosa: I. Purification of the antigen. J Immunol 1955; 74: 455-465.
25. Van Dongen J.J., Remie R., Rensema J.W., Van Wunnik R.H.J. Manual of Microsurgery on the Laboratory Rat. Amsterdam: Elsevier, 1990.
26. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035-10038.
27. Sundstrom S.A., Komm B.S., Ponce de Leon H., Yi Z., Teuscher C., Lyttle C.R. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 1989; 264: 16941-16947.
28. Misumi Y., Sohda M., Ikehara Y. Nucleotide and deduced amino acid sequence of rat complement C3. Nucl Acids Res 1990; 18: 2178.
29. Sargent T.D., Yang M., Bonner J. Nucleotide sequence of cloned rat serum albumin messenger RNA. Proc Natl Acad Sci USA 1981; 78: 243-246.
30. Strauss A.W., Bennett C.D., Donohue A.M., Rodkey J.A., Alberts A.W. Rat liver pre-proalbumin: complete amino acid sequence of the pre-piece. Analysis of the direct translation product of albumin messenger RNA. J Biol Chem 1977; 252: 6846-6855.
31. Isemura S., Ikenaka T. Amino acid sequences of fragments I and II obtained by cyanogen bromide cleavage of rat serum albumin. J Biochem Tokyo 1978; 83: 35-48.
32. Hellman L., Pettersson U., Engstrom A., Karlsson T., Bennich H. Structure and evolution of the heavy chain from rat immunoglobulin E. Nucl Acids Res 1982; 10: 6041-6049.
33. Vukajlovich S.W., Hoffman J., Morrison D.C. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. Mol Immunol 1987; 24: 319-331.
34. Vukajlovich S.W. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to Re-chemotype lipopolysaccharide and purified lipid A. Infect Immun 1986; 53: 480-485.
35. Grossman N., Leive L. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol 1984; 132: 376-385.
36. Beuscher H.U., Brade V. Lipopolysaccharides as complement inhibitors by complex formation with the purified third complement component (C3). Immunobiology 1986; 173: 41-55.
37. Botto M., Lissandrini D., Sorio C., Walport M.J. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 1992; 149: 1348-1355.
38. Strunk R.C., Whitehead A.S., Cole F.S. Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest 1985; 76: 985-990.
39. Nichols W.K. LPS stimulation of complement (C3) synthesis by a human monocyte cell line. Complement 1984; 1: 108-115.
40. Rothman B.L., Merrow M., Despins A., Kennedy T., Kreutzer D.L. Effect of lipopolysaccharide on C3 and C5 production by human lung cells. J Immunol 1989; 143: 196-202.
41. Freudenberg M.A., Galanos C. The metabolic fate of endotoxins. Prog Clin Biol Res 1988; 272: 63-75.
42. Freudenberg N., Freudenberg M.A., Bandara K., Galanos C. Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. Pathol Res Pract 1985; 179: 517-527.
43. Warren H.S., Chedid L.A. Strategies for the treatment of endotoxemia: significance of the acute-phase response. Rev Infect Dis 1987; 9(Suppl 5): S630-S638.
44. Tobias P.S., Ulevitch R.J. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). J Immunol 1983; 131: 1913-1916.
45. Tobias P.S., McAdam K.P., Soldau K., Ulevitch R.J. Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum. Infect Immun 1985; 50: 73-76.
46. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.